Literature DB >> 25519906

Post-transcriptional regulation of programmed cell death 4 (PDCD4) mRNA by the RNA-binding proteins human antigen R (HuR) and T-cell intracellular antigen 1 (TIA1).

Callie P Wigington1, Jeenah Jung2, Emily A Rye1, Sara L Belauret3, Akahne M Philpot4, Yue Feng5, Philip J Santangelo2, Anita H Corbett6.   

Abstract

Post-transcriptional processing of mRNA transcripts plays a critical role in establishing the gene expression profile of a cell. Such processing events are mediated by a host of factors, including RNA-binding proteins and microRNAs. A number of critical cellular pathways are subject to regulation at multiple levels that allow fine-tuning of key biological responses. Programmed cell death 4 (PDCD4) is a tumor suppressor and an important modulator of mRNA translation that is regulated by a number of mechanisms, most notably as a target of the oncomiR, miR-21. Here, we provide evidence for post-transcriptional regulation of PDCD4 by the RNA-binding proteins, HuR and TIA1. Complementary approaches reveal binding of both HuR and TIA1 to the PDCD4 transcript. Consistent with a model where RNA-binding proteins modulate the PDCD4 transcript, knockdown of HuR and/or TIA1 results in a significant decrease in steady-state PDCD4 mRNA and protein levels. However, fractionation experiments suggest that the mode of regulation of the PDCD4 transcript likely differs in the cytoplasm and the nucleus as the pool of PDCD4 mRNA present in the cytoplasm is more stable than the nuclear pool of PDCD4 transcript. We observe a competitive mode of binding between HuR and TIA1 on the PDCD4 transcript in the cytoplasm, suggesting that these two factors dynamically interact with one another as well as the PDCD4 transcript to maintain tight control of PDCD4 levels. Overall, this study reveals an additional set of regulatory interactions that modulate the expression of PDCD4, a key pro-apoptotic factor, and also reveals new insights into how HuR and TIA1 functions are integrated to achieve such regulation.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  HuR; Imaging; PDCD4; Post-transcriptional Regulation; RNA Processing; RNA-Protein Interaction; RNA-binding Protein; TIA1

Mesh:

Substances:

Year:  2014        PMID: 25519906      PMCID: PMC4319015          DOI: 10.1074/jbc.M114.631937

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  94 in total

Review 1.  Cytochrome c: the Achilles' heel in apoptosis.

Authors:  A V Kulikov; E S Shilov; I A Mufazalov; V Gogvadze; S A Nedospasov; B Zhivotovsky
Journal:  Cell Mol Life Sci       Date:  2011-12-17       Impact factor: 9.261

2.  The mRNA stability factor HuR inhibits microRNA-16 targeting of COX-2.

Authors:  Lisa E Young; Ashleigh E Moore; Lena Sokol; Nicole Meisner-Kober; Dan A Dixon
Journal:  Mol Cancer Res       Date:  2011-11-02       Impact factor: 5.852

3.  Probes for intracellular RNA imaging in live cells.

Authors:  Philip J Santangelo; Eric Alonas; Jeenah Jung; Aaron W Lifland; Chiara Zurla
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

4.  Promoter cloning and characterization of the human programmed cell death protein 4 (pdcd4) gene: evidence for ZBP-89 and Sp-binding motifs as essential Pdcd4 regulators.

Authors:  Jörg Hendrik Leupold; Irfan Ahmed Asangani; Giridhar Mudduluru; Heike Allgayer
Journal:  Biosci Rep       Date:  2012-06       Impact factor: 3.840

Review 5.  Mechanisms coordinating ELAV/Hu mRNA regulons.

Authors:  Laura E Simone; Jack D Keene
Journal:  Curr Opin Genet Dev       Date:  2013-01-09       Impact factor: 5.578

6.  The structure of the ARE-binding domains of Hu antigen R (HuR) undergoes conformational changes during RNA binding.

Authors:  Hong Wang; Fuxing Zeng; Qiao Liu; Huihui Liu; Zexian Liu; Liwen Niu; Maikun Teng; Xu Li
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-02-16

Review 7.  Functional interplay between RNA-binding protein HuR and microRNAs.

Authors:  Subramanya Srikantan; Kumiko Tominaga; Myriam Gorospe
Journal:  Curr Protein Pept Sci       Date:  2012-06       Impact factor: 3.272

8.  Genome-wide determination of RNA stability reveals hundreds of short-lived noncoding transcripts in mammals.

Authors:  Hidenori Tani; Rena Mizutani; Kazi Abdus Salam; Keiko Tano; Kenichi Ijiri; Ai Wakamatsu; Takao Isogai; Yutaka Suzuki; Nobuyoshi Akimitsu
Journal:  Genome Res       Date:  2012-02-27       Impact factor: 9.043

9.  Quantifying RNA-protein interactions in situ using modified-MTRIPs and proximity ligation.

Authors:  Jeenah Jung; Aaron W Lifland; Chiara Zurla; Eric J Alonas; Philip J Santangelo
Journal:  Nucleic Acids Res       Date:  2012-09-04       Impact factor: 16.971

10.  Competitive binding of CUGBP1 and HuR to occludin mRNA controls its translation and modulates epithelial barrier function.

Authors:  Ting-Xi Yu; Jaladanki N Rao; Tongtong Zou; Lan Liu; Lan Xiao; Miao Ouyang; Shan Cao; Myriam Gorospe; Jian-Ying Wang
Journal:  Mol Biol Cell       Date:  2012-11-14       Impact factor: 4.138

View more
  25 in total

Review 1.  T-cell intracellular antigens in health and disease.

Authors:  Carmen Sánchez-Jiménez; José M Izquierdo
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  Transcriptional regulation of importin-α1 by JunD modulates subcellular localization of RNA-binding protein HuR in intestinal epithelial cells.

Authors:  Yan Xu; Jie Chen; Lan Xiao; Hee Kyoung Chung; Yuan Zhang; Joseph C Robinson; Jaladanki N Rao; Jian-Ying Wang
Journal:  Am J Physiol Cell Physiol       Date:  2016-10-12       Impact factor: 4.249

3.  Quantification and Localization of Protein-RNA Interactions in Patient-Derived Archival Tumor Tissue.

Authors:  Emmeline L Blanchard; Danae Argyropoulou; Chiara Zurla; Sushma M Bhosle; Daryll Vanover; Philip J Santangelo
Journal:  Cancer Res       Date:  2019-09-03       Impact factor: 12.701

4.  PDCD4 regulates apoptosis in human peritoneal mesothelial cells and promotes gastric cancer peritoneal metastasis.

Authors:  Pei Wu; Jinou Wang; Xiaoyun Mao; Huimian Xu; Zhi Zhu
Journal:  Histol Histopathol       Date:  2021-01-14       Impact factor: 2.303

Review 5.  The versatile role of HuR in Glioblastoma and its potential as a therapeutic target for a multi-pronged attack.

Authors:  Abhishek Guha; Saboora Waris; Louis B Nabors; Natalia Filippova; Myriam Gorospe; Thaddaeus Kwan; Peter H King
Journal:  Adv Drug Deliv Rev       Date:  2021-12-16       Impact factor: 15.470

6.  NMR-derived secondary structure of the full-length Ox40 mRNA 3'UTR and its multivalent binding to the immunoregulatory RBP Roquin.

Authors:  Jan-Niklas Tants; Lea Marie Becker; François McNicoll; Michaela Müller-McNicoll; Andreas Schlundt
Journal:  Nucleic Acids Res       Date:  2022-04-22       Impact factor: 19.160

7.  A Novel Method to Quantify RNA-Protein Interactions In Situ Using FMTRIP and Proximity Ligation.

Authors:  C Zurla; J Jung; E L Blanchard; P J Santangelo
Journal:  Methods Mol Biol       Date:  2017

Review 8.  Can we observe changes in mRNA "state"? Overview of methods to study mRNA interactions with regulatory proteins relevant in cancer related processes.

Authors:  C Zurla; J Jung; P J Santangelo
Journal:  Analyst       Date:  2016-01-21       Impact factor: 4.616

Review 9.  RNA Binding Protein as an Emerging Therapeutic Target for Cancer Prevention and Treatment.

Authors:  Suntaek Hong
Journal:  J Cancer Prev       Date:  2017-12-30

10.  Targeting exosome-associated human antigen R attenuates fibrosis and inflammation in diabetic heart.

Authors:  Prem Kumar Govindappa; Mallikarjun Patil; Venkata Naga Srikanth Garikipati; Suresh K Verma; Sherin Saheera; Gayathri Narasimhan; Wuqiang Zhu; Raj Kishore; Jianyi Zhang; Prasanna Krishnamurthy
Journal:  FASEB J       Date:  2019-12-16       Impact factor: 5.834

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.